A Biopharma Pivot Story With Compugen's Dr. Anat Cohen-Dayag
Source: Bioprocess Online
Dr. Anat Cohen-Dayag transformed her company from a computational biology service provider to a clinical-stage biopharma with multiple cancer immunotherapy candidates, and she did it in a remarkably short period of time. Listen in as she discusses the human resources, financial, and capital strategies she deployed to build a biotech on the back of computational science, and shares her vision for the future of drug discovery.
This website uses cookies to ensure you get the best experience on our website. Learn more